As Trump continues to press for coronavirus vaccine by Election Day, public health officials vow ‘no cutting corners’

ASSOCIATED PRESS



a man wearing a suit and tie: Stephen Hahn, commissioner of the U.S. Food and Drug Administration, testifies Wednesday at a Senate Health, Education, Labor and Pensions Committee Hearing on the federal response to COVID-19.


© Associated Press
Stephen Hahn, commissioner of the U.S. Food and Drug Administration, testifies Wednesday at a Senate Health, Education, Labor and Pensions Committee Hearing on the federal response to COVID-19.

WASHINGTON (AP) — A huge international study of a COVID-19 vaccine that aims to work with just one dose is getting underway as top U.S. health officials sought Wednesday to assure a skeptical Congress and public that they can trust any shots the government ultimately approves.

Hopes are high that answers about at least one of several candidates being tested in the U.S. could come by year’s end.

‘President Trump is still trying to sabotage the work of our scientists and public health experts for his own political ends.’ — Sen. Patty Murray

“We feel cautiously optimistic that we will be able to have a safe and effective vaccine, although there is never a guarantee of that,”

Read More

U.S. health officials believe coronavirus vaccine could be widely available by April

STATEN ISLAND, N.Y. — Testifying before a senate committee Wednesday, United States health officials said they believed a coronavirus (COVID-19) vaccine would be ready for wide distribution by spring, 2021.

Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, said it is possible there are 50 million doses available by November, 100-plus million available by December and about 700 million available by January.

Robert Redfield, the director of the Centers for Disease Control and Prevention (CDC), reaffirmed this timeline to the Senate Committee on Health, Education, Labor and Pensions, saying, “We will have the 700 million doses based on projection by late March, early April.”

Fauci explained that the vaccine will not be available “to a large proportion” of the population initially, and that it is likely that health care professionals and those with underlying conditions would be the first to receive immunization, once it

Read More

Public Health Leaders Vow Science, Not Politics, Will Guide COVID-19 Vaccine

Updated at 1:37 p.m. ET

Amid criticism from Democrats that politics may be guiding decisions at the nation’s top health agencies, the commissioner of the Food and Drug Administration told Congress on Wednesday that a coronavirus vaccine would not be approved until it met “vigorous expectations” for safety and effectiveness.

“Decisions to authorize or approve any such vaccine or therapeutic will be made by the dedicated career staff at FDA through our thorough review processes, and science will guide our decisions,” FDA commissioner Stephen Hahn told senators.

Hahn continued: “FDA will not permit any pressure from anyone to change that. I will fight for science … I will fight for the integrity of the agency, and I will put the interests of the American people before anything else.”

Four of the top federal officials responsible for managing the coronavirus pandemic all testified before of the Senate Health, Education, Labor and

Read More

The Latest: US health officials want safe, effective vaccine

Dr. Robert Redfield, head of the Centers for Disease Control and Prevention, addressed criticism that forced the CDC to supersede its guidance. The clarification now says people without symptoms should be tested.

Redfield told

Read More

Watch Live: Public Health Leaders Vow Science, Not Politics, Will Guide Vaccine

Wednesday, September 23, 2020

Photo caption:

Updated at 11:20 a.m. ET

Amid criticism from Democrats that politics may be guiding decisions at the nation’s top health agencies, the commissioner of the Food and Drug Administration told Congress on Wednesday that a coronavirus vaccine would not be approved until it met “vigorous expectations” for safety and effectiveness.

“Decisions to authorize or approve any such vaccine or therapeutic will be made by the dedicated career staff at FDA through our thorough review processes, and science will guide our decisions,” FDA commissioner Stephen Hahn told senators.

Continued Hahn: “FDA will not permit any pressure from anyone to change that. I will fight for science … I will fight for the integrity of the agency, and I will put the interests of the American people before anything else.”

Four of the top federal officials responsible for managing the coronavirus pandemic are testifying

Read More